Madrigal Pharmaceuticals, Inc. (0JXI)
Market Closed
17 Jul, 15:30
$
545. 12
+6.72
+1.2491%
$
8.05B Market Cap
- P/E Ratio
- Div Yield
135 Volume
-19.39 Eps
$ 538.4
Previous Close Want to track 0JXI and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Madrigal Pharmaceuticals, Inc. (0JXI) Statistics
Valuation metrics
Market Cap 8.05B
Enterprise value 11.46B
Trailing P/E (ttm) -193.16
Forward P/E -
PEG ratio -13.33
Price/Sales (ttm) -
Price/Book (mrq) 22.17
Enterprise Value/Revenue 10.12
Enterprise Value/EBITDA -36.73
Overview
Shares outstanding 15.39M
Float 12.91M
Shares short -
% Held by insiders 0.06%
% Held by institutions 1.06%
Average volume (10 days) 33
Average volume (90 days) 51
Price summary
52-Week low 291
52-Week high 610.61
Beta -1.04
50-Day moving average 231.01
200-Day moving average 217.37
Dividends and splits
Forward annual dividend rate -
Forward annual dividend yield -
Trailing annual dividend rate -
Trailing annual dividend yield -
5-Year annual dividend yield -
Payout ratio -
Dividend Date -
Ex-Dividend Date -
Last split factor 1:35
Last split Date 25 Jul 2016
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 30 Sep 2022
Profitability
Profit margin -0.27%
Operating margin -0.3%
Operational effectiveness
Return on assets -0.18%
Return on equity -0.49%
Income Statement
Revenue (ttm) 1.13B
Revenue per share (ttm) 49.95
Quarterly revenue growth (yoy) 1.27%
Gross profit (ttm) 1.05B
EBITDA -312M
Net income to common (ttm) -309.44M
Diluted EPS (ttm) -14.65
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) 812.77M
Total cash per share (mrq) 35.25
Total debt (mrq) 347.31M
Total Debt/Equity (mrq) 63.91
Current ratio (mrq) 3.5%
Book value per share (mrq) 23.59
Cash Flow
Cash flow statement -268.1M
Levered free cash flow (LFCF) -156.4M
